Overview

Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if Rimexolone (FID 109980) is a safe and effective treatment of dry eye.
Phase:
Phase 3
Details
Lead Sponsor:
Alcon Research
Treatments:
Rimexolone